MPN Updates

December 2016

Issue link:

Contents of this Issue


Page 0 of 28

A © 2016 SLACK Incorporated Introduction MPN Updates is a digital publication that focuses on current research and standards of care for patients with myeloproliferative neo- plasms. Each issue invites the reader to learn more about diagnosis and treatment options, including emerging therapeutic agents, as well as the impact myeloproliferative neo- plasms have on patients. is issue of MPN Updates features news coverage from the 2016 U.S. Focus on Myelo- proliferative Neoplasms and Myelodysplastic Syndromes conference, which was held in Alexandria, Virginia in August. We highlight four myeloproliferative neoplasm (MPN) presentations from experts who discussed topics such as the ever-evolving landscape of MPN treatment, diagnostic criteria updates and much more. Additionally, Jerry Spivak, MD, and Srdan Verstovsek, MD, PhD, are featured in videos providing further insight about the conference. MPN Updates ISSUE 2 | VOL 3 | DECEMBER 2016 This newsletter is produced by SLACK Incorporated through a third-party independent grant by Incyte Corporation. 8 2 WHO updates diagnostic criteria for ET, PV and MF 6 VIDEO: Autoimmune disorders and myelodysplasia correlation Therapy for early- stage MF: Pros and Cons 12 VIDEO: Genetic profiling and MPN management 18 COMFORT, RESPONSE trials show sustained outcomes with JAK inhibitor 22 Q&A with David H. Henry, MD IN THIS ISSUE:

Articles in this issue

Links on this page

Archives of this issue

view archives of MPN Updates - December 2016